Hoth Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Hoth Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2023.
  • Hoth Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $8.91M.
  • Hoth Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $11.3M, a 87.5% increase from 2022.
  • Hoth Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $6.04M, a 66.8% decline from 2021.
  • Hoth Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $18.2M, a 109% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11.3M +$5.28M +87.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $6.04M -$12.2M -66.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $18.2M +$9.47M +109% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $8.73M +$1.27M +17.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $7.45M +$6.3M +545% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $1.15M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.